...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Results Projected to be Available on or about September 30, 2019 for Phase 3 BETonMACE Trial

Free
Message: Third Eye, AHA, US Listing

Yes, that’s how apabetalone works, which makes good sense of course as a strategy to increase circulating HDL particle number. In contrast, the CETP inhibitors raise HDL cholesterol by putting the breaks on the transfer of CEs from HDLs to other lipoproteins. For another very good review article on this particular theme : 

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(19)30003-8/fulltext

Share
New Message
Please login to post a reply